About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2024
2023
2022
2021
2020
2019
29
Jul 2020
16:30 E.S.T.
Cellectis to Hold Second Quarter 2020 Earnings Call on Thursday, August 6, 2020 at 7:30AM EDT
Read more
21
Jul 2020
16:30 E.S.T.
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing
Read more
06
Jul 2020
17:20 E.S.T.
To Fully Focus on Cellectis, Dr. André Choulika Retires From Calyxt’s Board of Directors
Read more
06
Jul 2020
16:50 E.S.T.
Cellectis Reports Clinical Hold Placed on MELANI-01 Study
Read more
29
Jun 2020
16:30 E.S.T.
Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020
Read more
25
Jun 2020
16:30 E.S.T.
Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies
Read more
Prev
21
22
23
24
25
Next